How Long Do Mounjaro Side Effects Last? A Timeline for Each Side Effect, Dose by Dose

Written by Nataliia Bondarchuk. Updated October 29, 2026.

Most Mounjaro side effects last from a few days to a few weeks after each dose change, then fade. Nausea, diarrhea and vomiting typically start within a day or two of an injection, are strongest in the first two to three days, and ease before the next weekly dose; the same cycle can return, usually milder, after each 2.5 mg increase. The Mounjaro label puts it plainly: the majority of nausea, vomiting and diarrhea occurred during dose escalation and decreased over time. Because the standard ladder adds a step every four weeks for up to 20 weeks, the period in which side effects come and go can last four to five months for someone climbing to 15 mg, and for most people it ends there. A few effects run on a different clock: hair shedding starts two to four months in and lasts a few months, injection-site redness lasts a day or two, and gallbladder or pancreas problems are not 'side effects that pass' but reasons to call a doctor. This guide gives the trial numbers, a timeline for each side effect, what shortens them, and the warning signs that do not wait.

The figures below come from the Mounjaro prescribing information, pooling the placebo-controlled diabetes trials. They show a clear dose relationship for nausea, diarrhea, vomiting and reduced appetite, and they show that most people on Mounjaro do not have each of these effects. Most reports were mild to moderate; severe gastrointestinal reactions occurred in about 1% at each dose, close to the 0.9% on placebo. In the weight-management trials of the same drug as Zepbound, the rates were higher, nausea 25 to 29%, because those trials used higher doses in people without diabetes, who tend to report more gut effects.

Tirzepatide slows stomach emptying and acts on appetite centres in the brain, and both effects are strongest when the drug level rises to a new peak. The body adapts to each level over a few weeks, partly through changes in how quickly the stomach empties and partly through tolerance in the nerve pathways that trigger nausea. The label's escalation, 2.5 mg for four weeks then 2.5 mg increases at least four weeks apart, is designed to give that adaptation time, and the trial rates come from people following it. People who stay longer on a step before increasing usually have fewer side effects, and lose no ground over the long run. The dose ladder and when to pause on it are in tirzepatide dosage.

Fatigue on tirzepatide has its own set of causes, most of them fixable, covered in does tirzepatide make you tired.

Hair shedding is the main one. It is mostly telogen effluvium, a temporary shift of hair follicles into their resting phase triggered by rapid weight loss and reduced intake. It typically appears two to four months after starting, lasts a few months and is followed by regrowth; in the Zepbound trials hair loss was reported by 4 to 5% against 1% on placebo, more often in women. The details are in does tirzepatide cause hair loss. Constipation also behaves differently from nausea: it does not fade with adaptation in the same way, because it reflects lower food and fluid intake, and it improves when those improve. Low blood sugar is not a timeline issue at all; it is a combination issue, appearing in people who also take insulin or a sulfonylurea, and it needs those medicines adjusted rather than waiting.

Tirzepatide has a half-life of about five days, meaning the level in the blood halves every five days. Most of the drug is gone within about four weeks of the last dose. Gut side effects usually fade within one to two weeks of stopping, as levels fall below the threshold that slows the stomach; appetite returns over a similar period, and with it, for many people, weight. What happens to weight after stopping, and how to plan for it, is in what happens when you stop tirzepatide. If you miss more than one dose and restart, the gut effects can return as if you were starting over, which is why prescribers sometimes restart at a lower step after a long gap.

Mounjaro and Zepbound are the same tirzepatide, so their side effects and timelines are the same; the higher rates on the Zepbound label reflect the trial populations and doses, as explained in Mounjaro vs Zepbound. Compared with semaglutide, the head-to-head SURMOUNT-5 trial found nausea, diarrhea and constipation at almost identical rates, less vomiting on tirzepatide and more injection-site reactions; the full comparison is in tirzepatide vs semaglutide. The escalation to tirzepatide's top dose takes 20 weeks against 16 for semaglutide, so the window in which side effects come and go is slightly longer.

The complete list, including rare effects, is on our tirzepatide side effects page.

Side effects often change as the dose goes up. Our guide to tirzepatide 5 mg lists the label rates at that dose.

Mounjaro's side effects are front-loaded. Nausea, diarrhea and vomiting peak in the first days after each injection and each dose increase, fade within days to a couple of weeks, and become uncommon once the dose is stable; in the trials only 3 to 7% stopped because of them. Constipation and fatigue follow how much you eat and drink, hair shedding follows a separate two-to-six-month course, and a short list of symptoms (severe abdominal pain, persistent vomiting, signs of gallbladder disease) should never be waited out. Taking the escalation slowly, eating small, low-fat meals and keeping fluids up are the measures that shorten the rest. What to expect on the scale over the same months is in tirzepatide weight loss by week.

This article summarizes the Mounjaro and Zepbound labels and published trials for general information. Persistent or severe symptoms should be assessed by your prescriber.